Results 1 to 10 of about 10,418 (114)

Postpartum acquired hemophilia presenting as compartment syndrome: a diagnostic challenge in the emergency department [PDF]

International Journal of Emergency Medicine
Background Acquired hemophilia A is an uncommon but potentially life-threatening bleeding disorder caused by autoantibodies against factor VIII. It can be associated with autoimmune disease, malignancy, or pregnancy. Case report We describe a 31-year-old
Waseem Mujahed, Ahmad Nama, Joseph Kalish, Qasim Nimer, Barry Hahn, Evan Avraham Alpert   +5 more
doaj   +2 more sources

Acquired Hemophilia A Presenting as Intramuscular Hematoma

Journal of Investigative Medicine High Impact Case Reports, 2018
Acquired hemophilia A poses a clinical and diagnostic challenge. Although rare, it is still the most common acquired factor deficiency. We present a case of acquired hemophilia A diagnosed in a 71-year-old female who presented with a right thigh hematoma
Ghassan Al-Shbool MD, Anusha Vakiti MD
doaj   +2 more sources

Biologics and Drug‐Induced Immunogenicity: A Case Report of Acquired Hemophilia A Presenting After Immunotherapy [PDF]

Clinical Case Reports
Acquired hemophilia A is a rare, potentially life‐threatening bleeding disorder caused by autoantibody inhibitors to coagulation factor VIII. We report the case of an 87‐year‐old female who presented with symptomatic bleeding and was subsequently ...
Kevin A. Murgas, Sundus Nasim, Stephen Poos, Jules A. Cohen, Anna Andrzejczyk   +4 more
doaj   +2 more sources

Acquired hemophilia A: a case report and review of the literature [PDF]

Journal of Medical Case Reports
Background Acquired hemophilia A is a rare autoimmune disease characterized by inhibitory antibodies against coagulation factor VIII, leading to an increased risk of bleeding. The relevance of this case lies in its high associated morbidity and mortality,
Juan-Alfonso Perotti-Abad, Álvaro Cabezas-Corado, Luis Astolfi-Labrador, María Baus-Domínguez, Guillermo Machuca-Portillo, María-Ángeles Serrera-Figallo, Daniel Torres-Lagares   +6 more
doaj   +2 more sources

Acquired Hemophilia A Secondary to an Immune Checkpoint Inhibitor: A Case Report

JTO Clinical and Research Reports, 2022
We report a case of a patient with extensive-stage SCLC who developed acquired hemophilia A during maintenance atezolizumab therapy. The patient initially presented with asymptomatic anemia, a prolonged acquired prothrombin time, and factor VIII (FVIII ...
James Fletcher, MBBS, Robert Bird, MBBS, Andrew J.W. McLean, MBBS, Kenneth O’Byrne, MD, Wen Xu, MBBS   +4 more
doaj   +1 more source

Acquired Hemophilia ‘A’ – An Uncommon Condition Presented with Common Manifestations

National Board of Examinations Journal of Medical Sciences, 2023
Hemophilia A is usually a congenital bleeding disorder, which manifest in males due to its X linked recessive pattern of inheritance. It commonly presents with bruises, uncontrolled bleeding post minor trauma or post circumcision, knee swelling etc ...
Deepak S. Laddhad, Vinayak Hingane, Bantu Ruthvick, Shubham Rajkumar Agrawal, Pavan Shrikrishna Gadge   +4 more
doaj   +1 more source

WHOLE GENOME SEQUENCE OF SARS-COV-2 FROM COVID-19 ACQUIRED HEMOPHILIA PATIENT

International Journal of Infectious Diseases, 2023
Intro: Acquired hemophilia is an atypical pathology of SARS-CoV-2 infection, which could be variant associated. Here, we share a sequence of the SARS-CoV-2 genome from patient with COVID-19 acquired haemophilia.
U.A. Zainulabid, A. Aslam, M. Hussain, I. Ibrahim, P. Periyasamy, N. Kamarudin, H.F. Ahmad   +6 more
doaj   +1 more source

Acquired hemophilia A that required surgical hemostasis of hematomas occupying oral cavity: a case report

Journal of Medical Case Reports, 2021
Background Acquired hemophilia A is a rare coagulopathy caused by inhibitors of blood coagulation factor VIII. Patients with acquired hemophilia A have a higher mortality risk (5–10%) than those with congenital hemophilia.
Keigo Maeda, Shinsuke Yamamoto, Naoki Taniike, Toshihiko Takenobu   +3 more
doaj   +1 more source

Acquired hemophilia A and plasma cell neoplasms: a case report and review of the literature

Journal of Medical Case Reports, 2020
Background Acquired hemophilia A is a rare autoimmune disease with clinically often significant bleeding diathesis resulting from circulating autoantibodies inhibiting coagulation factor VIII.
Katarzyna A. Jalowiec, Martin Andres, Behrouz Mansouri Taleghani, Albulena Musa, Martina Dickenmann, Anne Angelillo-Scherrer, Alicia Rovó, Johanna A. Kremer Hovinga   +7 more
doaj   +1 more source

A case of acquired hemophilia A and bullous pemphigoid following SARS-CoV-2 mRNA vaccination

Journal of the Formosan Medical Association, 2022
Acquired hemophilia is a rare disease resulting from autoantibodies against endogenous factor VIII (FVIII), which associates with bleeding and a high mortality rate. The pathophysiology is still unclear.
Pei-An Fu, Chien-Wei Chen, Ya-Ting Hsu, Kai-Che Wei, Peng-Chan Lin, Tsai-Yun Chen   +5 more
doaj   +1 more source